The Directorate General of Drug Administration (DGDA) have cleared Oxford-AstraZeneca COVID-19 vaccine for use after testing samples of the 5 million doses brought from India on Monday.

The first consignment of five million doses of Oxford-AstraZeneca Covid-19 vaccine purchased by Bangladesh from the Serum Institute of India Pvt Limited will arrive on Monday, Health Minister Zahid Maleque said Sunday.